Olympus Shares Hit 12-Week Low After FDA Warning Over Quality Systems

3-line summary

• Olympus's Tokyo-listed shares (7733) fell 12.92% to 1,770 yen on Tuesday, their lowest level since July 24, after the company disclosed an FDA warning letter dated October 7, according to Investing.com; the Nikkei rose 0.9% the same day.
• The FDA raised concerns over Olympus's quality management system and related procedures following inspections of US, Japanese, and European facilities in late 2025. The letter does not specify the exact violations or affected products.
• Olympus said it will submit a detailed response within 15 business days and provide regular updates until the FDA deems corrective actions adequate. The company said no additional customer action is needed, products remain safe when used per instructions, and the letter does not restrict manufacturing, distribution, sales, or new 510(k) applications.

This summary is our own processing of the source article; see the source link below for full context.